The congestive heart failure drugs market is anticipated to grow at a significant CAGR of 16.1% during the forecast period (2022-2028). Some of the congestive heart failure drugs such as angiotensin-converting enzyme inhibitors are given in a state of congestive heart failure. This works by relaxing the blood vessels of the heart. Some angiotensin-converting enzyme […]
